Gastrointestinal Oncology
Thank you making our sessions at the 42nd annual DDW® in Chicago, IL scientifically relevant and exciting! If you have specific feedback regarding speakers sponsored by Gastrointestinal Oncology (GIONC) Section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2012 in San Diego.
We are now accepting volunteers for DDW 2012 abstract review and topic/speaker suggestions. Please visit the Volunteer and Feedback Form to get involved.
One of our Section's abstracts, Interval colorectal cancers frequently have subtle macroscopic appearance: a 10 year-experience in an academic center, was accepted for presentation at the very successful AGA Clinical Science Plenary and Best of DDW 2011 Plenary sessions.
This year the GIONC section accepted the majority of the abstracts submitted (83 percent). The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers. The table below shows the change from last year:
|
GIONC Abstract Selection |
2010 |
2011 |
|
Total Abstracts submitted |
637 |
614 |
|
Accepted Abstracts |
536 |
509 |
|
Oral Presentations |
110 |
119 |
|
Posters |
426 |
390 |
|
Posters of Distinction |
33 |
71 |
The GIONC section sponsored Clinical and Translational Symposia, one State-of-the-Art Lecture, abstract based Research and Topic Fora, and one distinguished abstracts plenary. Our sessions were very well attended. The chart below outlines the sessions we sponsored at DDW 2011 and the number of people who attended the session. If you have feedback to share regarding any of these sessions please email Jennifer Gibson at AGA headquarters.
|
GIONC Sessions |
|
|
|
Saturday, 5/7/2011 |
Duration |
Attendance |
|
Topic Forum: Colorectal Cancer Screening |
.8:30 – 10 a.m. |
192 |
|
Research Forum: Growth and Apoptosis in GI Cancers |
8:30 – 10 a.m. |
40 |
|
Topic Forum: Research in Health Disparities and Access to Care in Colorectal Cancer Screening |
8:30 – 10 a.m. |
30 |
|
Research Forum: Pancreatic Cancer: Biology, Diagnosis and Treatment |
10:30 – 12 p.m. |
43 |
|
Translational Symposium: Targeting Key Signaling Pathways in GI Cancers |
10:30 – 12 p.m. |
110 |
|
State-of-the-Art Lecture: Genome-scale Approaches for Identifying Therapeutic Targets in Cancer |
.2:15 – 3:15 p.m. |
62 |
|
Research Forum: Biomarkers in GI Cancers |
.2:15 – 3:45 p.m. |
97 |
|
Sunday, 5/8/2011 |
||
|
Research Forum: Screening, Surveillance and Diagnosis of GI Cancers |
.8:30 – 10 a.m. |
102 |
|
Translational Symposium: Biology of Right vs. Left-sided Colon Cancers |
10:30 – 12 p.m. |
375 |
|
Research Forum: Chemoprevention of GI Cancers |
10:30 – 12 p.m. |
70 |
|
Topic Forum: Epidemiology of Colon Cancer |
.2:15 – 3:45 p.m. |
60 |
|
Research Forum: Lynch Syndrome and Microsatellite Instability |
2:15 – 3:45 p.m. |
45 |
|
Gastrointestinal Oncology Distinguished Abstracts Plenary |
4 – 5:30 p.m. |
90 |
|
Gastrointestinal Oncology Section Townhall Meeting |
5:30 – 6:30 p.m. |
unknown |
|
Monday, 5/9/2011 |
||
|
Research Forum: Neuroendocrine Tumors |
.8:30 – 10 a.m. |
55 |
|
Research Forum: Targeted Therapy and GI Cancers |
8:30 – 10 a.m. |
85 |
|
Research Forum: Molecular Pathways in Colon Cancer |
2:15 – 3:45 p.m. |
65 |
|
Clinical Symposium: Cancer Screening In High-risk Genetic Syndromes |
4 – 5:30 p.m. |
110 |
|
Research Forum: Tumor Suppressor Genes in GI Cancers |
4 – 5:30 p.m. |
60 |
|
Tuesday, 5/10/2011 |
||
|
Topic Forum: Gastric Cancer: Biology, Diagnosis and Treatment |
.8:30 – 10 a.m. |
50 |
|
Clinical Symposium: Modern Management of Hepatocellular Carcinoma |
8:30 – 10 a.m. |
90 |
|
Research Forum: EMT and the Microenvironment in GI Cancers |
10:30 – 12 p.m. |
45 |
|
Research Forum: Esophageal Neoplasms and Barrett's Esophagus: Biology, Diagnosis and Treatment |
10:30 – 12 p.m. |
60 |
|
Research Forum: Influence of Inflammation and the Microbiome in GI Cancers |
2:15 – 3:45 p.m. |
60 |
|
Research Forum: Biomarkers in GI Cancers II |
4 – 5:30 p.m. |
30 |
|
Research Forum: Molecular Carcinogenesis of Colorectal Cancer |
4 – 5:30 p.m. |
40 |
Each June, GIONC section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (GIONC descriptors may change as we go forward to DDW 2012.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Gastrointestinal Oncology were shared at DDW.
|
Descriptor Name |
Abstracts Received |
Abstract Review Chair |
Abstract Reviewers |
|
Screening |
|
Jason Dominitz |
Harold Frucht, Sonia Kupfer, Paul Rozen, Mohammad Wehbi |
|
Prevention and Chemoprevention |
|
Frank Sinicrope |
Robert Bresalier, John Inadomi |
|
Biomarkers: Implications in Detection, Treatment and Prognosis of GI Cancers |
|
David Weinberg |
Andrew Chan, Fay Kastrinos, Temitope Keku |
|
Cancer Susceptibility and Familial Cancer Syndromes |
|
Randall Burt |
Lisa Boardman, Carol Burke, Patrick Lynch |
|
Molecular and Cancer Epidemiology: Genetic Mutations and Polymorphisms, Basic and Clinical Aspects |
|
David Weinberg |
Andrew Chan, Fay Kastrinos, Temitope Keku |
|
Esophageal Neoplasms: Precursors, Biology, Diagnosis and Therapy |
|
Hiroshi Nakagawa |
Claudia Andl, Wael El-Rifai, Yvonne Romero |
|
Pancreatic Neoplasms: Precursors, Biology, Diagnosis and Therapy |
|
Sushovan Guha |
Frank Gress, Matthias Lohr, Yusuke Mizukami |
|
Therapy for GI Cancers: Mechanisms of Chemotherapy and Drug Resistance, Novel Translational, Therapeutic and Targeted Approaches |
|
Kenneth Hung |
Stefania Asciutti, Bhaumik Patel, Hidekazu Suzuki |
|
Infection, Inflammation and IBD-associated GI Cancers |
|
Steven Itzkowitz |
Thomas Ullman, Vijay Yajnik |
|
Influences of Obesity, Nutrition, Microbiome and Environment on GI Cancers |
|
Peter Holt |
Dan Dixon, Hellan Kang, Rohit Loomba |
|
Rare GI Tumors: Lymphomas, Sarcoma, Gastrointestinal Stromal Tumors (GIST), Carcinoid and Neuroendocrine Tumors |
|
Bertram Wiedenmann |
Martyn Caplin, Michelle Kim |
|
Mechanisms of Carcinogenesis and Metastasis |
|
Scott Kuwada |
Punita Dhawan, Beth McConnell, Doug Stairs |
|
GI Cancers: Proliferation and Apoptosis, Senescence, DNA Repair and Cell Cycle Regulation |
|
B. Mark Evers |
Chris Cartwright, Heekyung Chung |
|
Molecular Genetics: Growth Factors, Receptors and Signal Transduction |
|
Jonathan Katz |
Marie-Josee Boucher, Jimmy Chow, Chris Williams |
|
Molecular Genetics: Genomics, Proteomics, Epigenomics and Epigenetics, Chromosomal and Microsatellite Instability |
|
C. Richard Boland |
Antoni Castells, Ajay Goel |
|
Molecular Genetics: Oncogenes and Tumor Suppressor Genes |
|
William Grady |
Tushar Patel, Chris Williams |
|
Tumor and Cell Biology |
|
Chris Yun |
Wolfram Goessling, Mark Hellmich, Kenneth Hung |
|
Tumor Microenvironment, Angiogenesis, Invasion and Epithelial-stromal Interaction |
|
J. Adrian Lunn |
Barbara Jung, John Lynch |
|
GI Cancers: Stem Cells and their Identification, Characterization and Therapeutic Implications, and Epithelial-mesenchymal Transition (EMT) |
|
Ben Stanger |
Courtney Houchen, C. Bart Rountree, Melissa Wong |
|
Liver and Biliary Neoplasm: Precursors, Biology, Diagnosis and Therapy |
|
Adam Slivka |
Abdullah Al-Osaimi, John Martin, David Wang |
|
Molecular Diagnostic Imaging of GI Cancers |
|
Thomas Wang |
Nadir Arber, Michael Wallace |
|
Novel Endoscopic Therapeutics of GI Cancers |
|
Nadir Arber |
James Farrell, Ganapathy Prasad |
|
Gastric Neoplasms: Precursors, Biology, Diagnosis and Therapy* |
|
Juanita Merchant |
Steven Moss, John Kao |
Note: Descriptors with an asterisk (*) are shared with at least one other Council section.
Section leaders will review committee membership this summer for new abstract review committees to confirm the final composition for DDW 2012 committees.If you are interested in serving as a reviewer for any of our abstract descriptors for DDW 2012, please fill out this form to volunteer. Please indicate the abstract descriptor for which you are interested in reviewing. You can also recommend any new descriptors for abstracts. GIONC section members interested in serving in this capacity are encouraged to contact us and volunteer to review abstracts. We are accepting volunteers through the end of July. You can join the GIONC section at any time.
In addition, we encourage you to submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please fill out this form to submit your suggestions to the AGA Institute by July 1, 2011.
Members interested in participating in the various activities of the section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.
Thank you for your continuing strong support of the GIONC section.
Sincerely,
John M. Carethers, MD, AGAF
Chair, GIONC Section, AGA Institute Council
Daniel C. Chung, MD
Vice-Chair, GIONC Section, AGA Institute Council
